Stock vs Stock Comparison

Boston Scientific Corporation vs Absci Corporation

BSX wins the Tale of the Tape 6–3.

BSX$47.69
ABSI$5.94

🏆 Tale of the Tape

63
BSXABSI
14.4%Profitability (Net Margin)-4113.7%
20.2xValuation (P/E)
7.7%Efficiency (ROIC)-46.9%
7/9Health (Piotroski F)2/9
3.9Safety (Altman Z)5.1
19.9%Growth (Rev YoY)-38.2%
-1.50Risk (Sharpe 1Y)0.56
0.78xBalance Sheet (D/E)0.14x
3.37%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.088
252-Day Correlation
0.113
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricBSXABSI
Market Cap$71.8B$1.1B
P/E Ratio20.2x
Forward P/E12.9x-10.6x
P/B2.78x6.10x
Dividend Yield
Beta0.622.38

Quantitative Metrics

MetricBSXABSI
DCF Fair Value$75.06
DCF Upside+18.8%
Piotroski F7/92/9
Altman Z3.885.11
Beneish M-2.52
FCF Yield3.37%-21.57%
Net Debt/EBITDA1.8x
ROIC7.7%-46.9%
WACC9.1%
ROIC – WACC-1.4pp
Gross Margin69.0%
Net Margin14.4%-4113.7%
Rev Growth YoY19.9%-38.2%
Sharpe (1Y)-1.500.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio

BSX Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

BSX found in:

IHI4.20%
XLV1.58%
XHE1.40%
VHT1.38%
MGK0.44%
SCHV0.38%
VUG0.26%
SPLG0.25%
IWD0.25%
IVV0.24%
ITOT0.21%
VONV0.21%
RSP0.20%
ESGV0.19%
SCHX0.18%
SCHB0.17%
SPYG0.16%
VFMV0.16%
ACWI0.15%
VOO0.14%
URTH0.13%
SPY0.13%
VONE0.13%
SPTM0.12%
VTI0.12%
QUS0.12%
SPYV0.10%
VT0.08%
IWF0.06%
VONG0.05%
ONEO0.02%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

BSX vs ABSI: Head-to-Head Analysis

Boston Scientific Corporation (BSX) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, BSX leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, BSX generates a return on invested capital (ROIC) of 7.7% compared to ABSI's -46.9%. This suggests BSX is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between BSX and ABSI is 0.088, indicating low correlation, making them an effective diversification pair in a portfolio context.

BSX appears in 31 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, BSX or ABSI?

Our quantitative analysis compares BSX and ABSI across nine fundamental dimensions. BSX wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are BSX and ABSI correlated?

The 252-day correlation between BSX and ABSI is 0.088. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.